Bookmark and Share
LFM A13 (CID 54676905) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(28)
 
 
Inactive(649)
 
 
Inconclusive(39)
 
 
Unspecified(749)
 
 
Top Targets:
7tm 4(41)
 
 
 
Pyr redox dim(10)
 
 
ANK(9)
 
 
HELICc(8)
 
 
 
STKc PLK3(7)
 
 
 
BioAssay Types:
Confirmatory(984)
 
 
 
 
 
Screening(341)
 
 
 
 
Literature(130)
 
 
 
 
Summary(1)
 
 
BioActivity Types:
IC50(707)
 
 
 
 
Potency(307)
 
 
 
 
Ki(3)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 1314    Data Row: 1465   Total Pages: 74   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103515372]
IC50 2.5Inhibition of BTK [AID370569, Type: Literature]
View
2
[SID103515372]
IC50 2.5Inhibition of recombinant BTK [AID325651, Type: Literature]
View
3
[SID103515372]
IC50 2.5Inhibition of human recombinant BTK expressed in baculovirus expression vector system [AID671740, Type: Literature]Tyrosine-protein kinase BTK [gi:547759]
View
4
[SID103515372]
IC50 7.2Inhibition of human PLK3 measured by Dixon plot [AID284676, Type: Literature]Serine/threonine-protein kinase PLK3 [gi:51338822]
View
5
[SID103515372]
IC50 10Inhibition of Plx1 [AID325652, Type: Literature]
View
6
[SID103515372]
IC50 10.3Inhibition of xenopus recombinant Plx1 expressed in Sf21 cells by measuring autophosphorylation by 15-mins kinase assay [AID284650, Type: Literature]
View
7
[SID103515372]
IC50 17.2Inhibition of human BTK [AID325650, Type: Literature]Tyrosine-protein kinase BTK [gi:547759]
View
8
[SID103515372]
IC50 17.4534SANGER: Inhibition of human NB6 cell growth in a cell viability assay. [AID742394, Type: confirmatory]
View
9
[SID103515372]
IC50 17.9747SANGER: Inhibition of human CAKI-1 cell growth in a cell viability assay. [AID741998, Type: confirmatory]
View
10
[SID103515372]
IC50 19.8731SANGER: Inhibition of human SNU-449 cell growth in a cell viability assay. [AID741890, Type: confirmatory]
View
11
[SID103515372]
IC50 20.8679SANGER: Inhibition of human PC-14 cell growth in a cell viability assay. [AID741809, Type: confirmatory]
View
12
[SID103515372]
IC50 30.2916SANGER: Inhibition of human SK-N-DZ cell growth in a cell viability assay. [AID741877, Type: confirmatory]
View
13
[SID103515372]
IC50 32.5Inhibition of Xenopus recombinant Plx1 expressed in Sf21 cells by GST-Cdc25 substrate phosphorylation assay [AID284651, Type: Literature]
View
14
[SID103515372]
IC50 37.8956SANGER: Inhibition of human A704 cell growth in a cell viability assay. [AID741956, Type: confirmatory]
View
15
[SID103515372]
IC50 41.3257SANGER: Inhibition of human EKVX cell growth in a cell viability assay. [AID742143, Type: confirmatory]
View
16
[SID103515372]
IC50 41.4395SANGER: Inhibition of human SW13 cell growth in a cell viability assay. [AID741900, Type: confirmatory]
View
17
[SID103515372]
IC50 42.5215SANGER: Inhibition of human BxPC-3 cell growth in a cell viability assay. [AID741990, Type: confirmatory]
View
18
[SID103515372]
IC50 43.9854SANGER: Inhibition of human EW-7 cell growth in a cell viability assay. [AID742165, Type: confirmatory]
View
19
[SID103515372]
IC50 44.6703SANGER: Inhibition of human HuO-3N1 cell growth in a cell viability assay. [AID742239, Type: confirmatory]
View
20
[SID103515372]
IC50 47.0373SANGER: Inhibition of human ES7 cell growth in a cell viability assay. [AID742151, Type: confirmatory]
View